Janet Roberts

Management of Pre-Existing Inflammatory Arthritis During Immune Checkpoint Inhibitor Therapy for Metastatic Renal Cell Cancer with a TNF Inhibitor for over 6 Years: A Case Report

Background The use of immune checkpoint inhibitors (ICIs) has transformed cancer care by using the body’s own immune system to target malignant cells. ICIs can cause unintended off-target effects, termed immune related adverse events (irAEs), which can be de novo or related to pr...